Market World Next Generation Sequencing Market | Page 2

NGS has been mostly a topic of research and development in the previous decade. At present they find
applications in the field of oncology, prenatal testing, HLA testing, idiopathic diseases, and medical research.
Research and development in the field of HLA and prenatal testing have provided new avenues to doctors in
gaining insights during organ matching and organ rejection.
The development in the treatment of genetic anomalies and diseases with the help of prenatal genome
sequencing has been driving the NGS market. This technology has also helped the pharmaceutical companies in
developing essential drugs for the treatment of cancer and infectious diseases. Growing concerns and increasing
incidences of cancer is expected to be the major driving factor for the development of NGS.
NGS in the field of organ transplant provides great opportunities over the forecast period. It is important that
the characteristics of both the donors and the acceptors match for a successful transplant. NGS helps in studying
the immune response to the transplanted organ. Medical tourism development in countries including the U.S,
Israel, Singapore and Australia provide bright prospects for overall growth of the market.
Next generation sequencing market is segmented as target, genome, exon and resequencing. The largest share
is held by target sequencing followed by genome sequencing. Development of whole genome sequencing
capabilities is expected to show a significant growth over the forecast period. Whole genome technology is
relatively new and is gaining popularity with the development of high throughput. This high throughput has
helped in reducing complications associated with whole genome sequencing.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market
NGS includes sample enrichment, DNA tagging, library preparation, sample quality assurance, DNA
quantification, data storage, genetic data assembly, analysis and interpretation. With the increase in volume of
whole genome sequencing, next generation data analysis is expected to observe a significant growth over the
forecast period.
Government regulatory bodies play a vital role in overall development and usage of these technologies. Medical
device manufacturers in the U.S. are under the strict vigilance of Food and Drug Administration (FDA). In 2013,
FDA approved four next generation gene sequencing devices which is expected to help physicians in taking a
broader look at the patient’s genetic makeup. Two of the approved devices is expected to help in detecting DNA
changes in the treatment of cystic fibrosis.
North America is expected to observe highest demand in the global industry on account of the well-developed
healthcare sector and implementation of advanced research infrastructure. Similarly, Western Europe is